Drug Profile
Research programme: cancer therapeutics - Molecular Therapeutics/Roche
Latest Information Update: 03 Aug 2015
Price :
$50
*
At a glance
- Originator Molecular Therapeutics; Roche
- Class Drug conjugates; Proteins
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cancer